37267 Is the Licox PtO2 System Reliable for Free Flap Monitoring? Comparison between Two Cohorts of Patients

Saturday, September 29, 2018: 9:00 AM
Chiara Stocco, MD , Plastic and Reconstructive Surgery Unit, Department of Medical, Surgical and Health Sciences, University of Trieste, Italy, Trieste, Italy
Vittorio Ramella, MD , Plastic and Reconstructive Surgery Unit,, Department of Medical, Surgical and Health Sciences, University of Trieste, Italy, Trieste, Italy
Giovanni Papa, MD, PhD , Plastic and Reconstructive Surgery Unit, Department of Medical, Surgical and Health Sciences,University of Trieste, Italy, Trieste, Italy
Federico Cesare Novati, MD , Plastic and Reconstructive Surgery Unit, Department of Medical, Surgical and Health Sciences, University of Trieste, Italy, Trieste, Italy
Sara Leuzzi, MD , Plastic and Reconstructive Surgery Unit, Department of Medical, Surgical and Health Sciences, University of Trieste, Italy, Trieste, Italy
Zoran Marij Arnez, MD, PhD , Plastic and Reconstructive Surgery Unit, Department of Medical, Surgical and Health Sciences, University of Trieste, Italy, Trieste, Italy

Background Flap failures can derive from arterial or venous occlusion due to thrombosis, external compression, vessel kinking, or hematoma, etc. Any delay between the detection of flap compromise and surgical re-exploration significantly decreases the free flap salvage rate. Free Flap monitoring is crucial for early recognition of vascular complications. Licox® PtO2 is a minimally invasive monitoring system for continuous measurement of tissue oxygen tension in all types of free tissue transfers. Our study compares two consecutive series of patients undergoing microsurgical reconstruction monitored with standard clinical bedside surveillance and with the Licox® PtO2 system regarding flap loss and flap salvage, sensitivity and specificity.

Methods: We performed a prospective study of all patients undergoing microsurgical reconstructions between 2016 and 2017. Group 1 included 43 patients that underwent standard clinical bedside postoperative flap monitoring while group 2 included 44 consecutive patients also monitored with Licox® PtO2 system.
Flap complications such as return to theatre for vascular compromise, partial and total flap loss and flap salvage rate were analyzed. We performed the re-exploration of the flap in group 2, when the PtO2 values continuously dropped for at least 50% of their original value in 30 minutes or reached levels lower than ten mmHg while in group 1, clinical signs of arterial/venous compromise had to be present.

Differences in categorical data were analyzed using Chi-square test or Fisher's exact test when appropriate. Differences were considered significant if P-value was <0.05. Statistical analyses were carried out using software R (the R Foundation for Statistical Computing; Version 3.3.2, 2016).

Results: Between 2016 and 2017, we performed 87 microsurgical flaps. We monitored 43 free flaps with clinical assessment (group 1) and 44 with the Licox® PtO2 system (group 2). We used different types of free flaps for breast, head and neck, lower limb and genital reconstruction (DIEP, mSAP, ALT, fibular flap, LD, TFL, RFFF, UFFF).

We noticed no significant difference between the two groups regarding the rate of vascular complications (p=0.31) return to the theatre (p=0.31), flap salvage (p=0.9), total and partial flap loss (p=0.49 and 0.36 respectively). We recorded a total of 10 vascular complications: 6 in group 1 and 3 in group 2.
When analyzing the Licox® PtO2 system monitoring group, we documented six false-positive results (13.6%) and 0 false negatives with an accuracy of 0.86, a sensibility of 1.00 and a specificity of 0.85 (with positive and negative predictive value of 0.33 and 1.00 respectively).

Conclusions: Licox® PtO2 system detects early postoperative circulation problems in all types of free microvascular flaps, including buried and bone ones. The high sensitivity of this method gives a promising safety profile when the values remain stable without any alarm signal. Its lower specificity (high percentage of false-positive results) requires additional clinical monitoring; this could be related to the lack of precise guidelines regarding the probe insertion (the distance from the perforator etc.). To date, in our experience, it can be used as a useful supplement to clinical bedside observation of free flaps because of its low specificity